Mr. McKee joined C4 Therapeutics as our interim Chief Financial Officer in April 2020. Mr. McKee currently serves as Chief Executive Officer of MBJC Associates, LLC, a business consulting firm serving the pharmaceutical and biotech industry. Mr. McKee served as Chief Operating Officer and Chief Financial Officer for EKR Therapeutics, Inc., or EKR, from July 2010 until June 2012 when EKR was sold to Cornerstone Therapeutics Inc. Until March 2010, Mr. McKee served as the Executive Vice President, Chief Financial Officer and Treasurer of Barr Pharmaceuticals, LLC, a subsidiary of Teva Pharmaceutical Industries Limited. Mr. McKee was also Executive Vice President and Chief Financial Officer of Barr prior to its acquisition by Teva. Mr. McKee currently serves on the boards of publicly traded companies including Assertio Therapeutics, Inc. (formerly known as Depomed, Inc.), Agile Therapeutics and Aileron Therapeutics, Inc. He was a director at Cerulean Pharma Inc., until it was acquired by Daré Bioscience Operations, Inc. in July 2017 and Auxilium Pharmaceuticals, Inc. until it was acquired by Endo International plc in January 2015. Mr. McKee received his Bachelor of Business Administration degree from the University of Notre Dame.